Profit & Revenue
Brands News

AstraZeneca Beat Expectations For Q1 Profit & Revenue

AstraZeneca on Thursday beat expectations for its first-quarter profit and revenue, helped by sales of its roster of drugs in emerging markets. The London-listed drugmaker, which reports its results in U.S. dollars, reported an adjusted profit of USD 1.92 per share on sales of about USD 10.9 billion. Analysts on average were expecting USD 1.71 […]

Read More